Metoclopramide for chronic nausea in adult palliative care patients with advanced cancer

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Clark, Katherine ^a   Agar, Meera R ^b   Currow, David ^b  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE;

ADVANCED CANCER; ARTICLE; CANCER PALLIATIVE THERAPY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HUMAN; NAUSEA; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 85041734446     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008387.pub2     Document Type: Article

References (29)

1. Bruera E, Brenneis C, Michaud M. Continuous subcutaneous infusion of metoclopramide for treatment of narcotic bowel syndrome. Cancer Treatment Reports 1987;71(11):1121-1.
2. Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. Journal of Pain & Symptom Management 2000;19(6):427-35.
3. Bruera E, Moyano JR, Sala R, Rico MA, Bosnjak S, Bertolino M, et al. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. Journal of Pain & Symptom Management 2004;28(4):381-8.
4. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 2004;329(7479):1369-73.
5. Deeks JJ, Higgins JPT, Altman DG, editors. In: Higgins JPT, Green S, editors. Analysing data and undertaking meta-analysis. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0. Chichester, UK: Wiley-Blackwell, 2008.
6. Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesthesia & Analgesia 1999;88(6):1370-9.
7. Dontthireddy KR, Ailawadhi S, Nasser E, SchiffMD, Nwogu CE, Nava HR, et al. Malignant gastroparesis: pathogenesis and management of an under recognised disorder. Journal of Supportive Oncology 2007;5(8):355-63.
8. Fujita Y, Yasukawa T, Mihira M, Sasaki T, Yokoya S. Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome. Intensive Care Medicine 1996;22(7):717.
9. Glare P, Dunwoodie D, Clark K, Ward A, Yates P, Hardy J. Treatment of nausea and vomiting in terminally ill cancer patients. Drugs 2008;68(18):2575-90.
10. Haans JJ. Masclee AA. Review article: The diagnosis and management of gastroparesis. Alimentary Pharmacology & Therapeutics 2007;26 suppl(2):37-46.
11. Habib AS, Gan TJ. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. Journal of Clinical Anesthesia 2005;17(1):62-5.
12. Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos P, et al. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Supportive Care in Cancer 2002;10(3):231-6.
13. Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. British Journal of Anaesthesia 1999;83(5):761-71.
14. Hesketh PJ. Chemotherapy-induced nausea and vomiting. NEJM 2008;358(23):2482-94.
15. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
16. Hirayama T, Ishii F, Yago K, Ogata H. Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review. Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan 2001;121(2):179-85.
17. Hiyama T, Yoshihara M, Matsuo K, Kusunoki H, Kamada T, Ito M, et al. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. Journal of Gastroenterology & Hepatology 2007;22(3):304-10.
18. Khan NU, Razzak JA. Abdominal pain with rigidity secondary to the anti-emetic drug metoclopramide. Journal of Emergency Medicine 2006;30(4):411-3.
19. Mystakidou K. Befon S. Liossi C. Vlachos L. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Cancer. 1998;83(6):1214-23.
20. Nagula S, Schattner M. Malignant gastroparesis: diagnosis and therapeutics. Journal of Supportive Oncology 2007;5(8):366-7.
21. Pasricha P, Pehlivanov N, Sugumar A, Jankovic J. Drug Insight: from disturbed motility to disordered movement-a review of the clinical benefits and medicolegal risks of metoclopramide. Nature Clinical Practice Gastroenterology & Hepatology 2005;3(3):139-48.
22. Pasricha P. The riddle, mystery and enigma of gastroparesis. The Journal of Supportive Oncology 2007;5:368-70.
23. Pater J, Slamet L, Zee B, Osoba D, Warr D, Rusthoven J. Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting. Supportive Care in Cancer 2004;2(3):161-6.
24. Portenoy R, Thaler H, Kornblith A, Lepore J, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research 1994;3:183-9.
25. Sturm A, Holtmann G, Goebell H, Gerken G. Prokinetics in patients with gastroparesis: a systematic analysis. Digestion 1999;60(5):422-7.
26. Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Alimentary Pharmacology and Therapeutics 2004;19:373-90.
27. Twycross R, Back I. Nausea and vomiting in advanced cancer. European Journal of Palliative Care 1998;5:39-45.
28. Wilson J, Plourde JY, Marshall D, Yoshida S, Chow W, Harsanyi Z, et al. Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. Journal of Palliative Care 2002;18(2):84-91.
29. Wood GJ, Shega JW, Lynch B, Von Roenn JH. Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time. nothing was working". JAMA 2007;298(10):1196-207.